1 Min Read
Oct 19 (Reuters) - Swedish Orphan Biovitrum Ab (Publ)
* Says EU commission gives SOBI003 orphan drug status for treatment of MPS IIIA Further company coverage: (Reporting by Stockholm Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.